Governance Metagenomi Therapeutics, Inc.

MGX

US59102M1045

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-06 pm EST			5-day change	1st Jan Change
1.480 ^USD	-8.07%		-2.63%	-8.64%

Mar. 05	Metagenomi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 04	Metagenomi Therapeutics, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 11:10 AM

Executive Committee: Metagenomi Therapeutics, Inc.

Manager

Positions heldSince

Jian Irish

62 year

Chief Executive Officer

2025-11-10

Simren Delaney

40 year

General Counsel

2020-01-31

Pamela Wapnick

60 year

Director of Finance/CFO

2023-08-31

Matthew Wein

55 year

Compliance Officer	2024-01-31
General Counsel	2024-01-31
Corporate Secretary	2024-01-31

Composition of the Board of Directors: Metagenomi Therapeutics, Inc.

Director

CommitteesSince

Willard Dere

72 year

Compensation Committee	2016-07-17
Audit Committee	2017-07-10

Eric Bjerkholt

66 year

Audit Committee Chair
Audit Committee	2023-04-04
Compensation Committee	2025-01-26
Governance Committee
Nominating Committee

Jürgen Eckhardt

59 year

Compensation Committee
Governance Committee
Nominating Committee
Audit Committee Chair	2024-01-31

Laurence Reid

63 year

Governance Committee	2024-11-22
Nominating Committee	2024-11-22

Brian Thomas

57 year

Director/Board Member

2025-11-10

Jian Irish

62 year

Director/Board Member

Latest Appointments: Metagenomi Therapeutics, Inc.

Nov. 11	Metagenomi, Inc. Announces CEO Changes	CI
Nov. 11	Metagenomi, Inc. to Appoint Willard Dere as New Board Chair	CI
25-08-11	Metagenomi, Inc. Appoints Laurence Reid, PhD to its Board of Directors	CI
25-01-15	Metagenomi, Inc. Appoints Eric Bjerkholt as Class II Director and Member of Audit and Compensation Committees, Effective January 27, 2025	CI

More news

Former Officers and Directors: Metagenomi Therapeutics, Inc.

Insider

Positions held

SinceUntil

Sarah Noonberg

Chief Tech/Sci/R&D Officer

2022-12-31

2025-07-31

Sebastián Bernales

Director/Board Member	2020-11-30	2025-06-09
Independent Dir/Board Member	2020-11-30	2025-06-09

Simon Harnest

Chief Investment Officer

2021-06-30

2024-12-31

Michael Conway

Corporate Officer/Principal

2022-02-28

2024-09-30

Luis Borges

Chief Tech/Sci/R&D Officer

2023-07-31

2024-07-14

Risa Stack

Director/Board Member

2022-03-31

2024-01-31

Santhosh Palani

Director/Board Member

2021-12-31

2024-01-16

Jak Knowles

Director/Board Member

2019-05-31

2021-11-30

Andrew Levin

Director/Board Member

2021-04-06

Andrew Farquharson

Director/Board Member

Jillian Banfield

Founder

Age distribution of managers

Parity Men Women

Male	10
Female	1

Of which Executive Committee

Male	3
Female	1

Of which Directors

Male	6
Female	0

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.

Employees

124

Sector

Biotechnology & Medical Research

More about the company